TDAC Stock Chart & Stats
$10.61
--
Market closed
$10.61
--
Day’s Range― - ―
52-Week Range$10.25 - $10.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)12.43K
Market Cap
$234.63M
Enterprise Value$235.65M
Total Cash (Recent Filing)$24.63K
Total Debt (Recent Filing)$500.00K
Price to Earnings (P/E)37.2
Beta0.01
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.29
Shares Outstanding21,907,500
10 Day Avg. Volume529
30 Day Avg. Volume12,426
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)1.03
Price to Sales (P/S)0.00
P/FCF Ratio-297.43
Enterprise Value/Market Cap1.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-268.31
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Translational Development Acquisition Corp. News
TDAC FAQ
What was Translational Development Acquisition Corp.’s price range in the past 12 months?
Translational Development Acquisition Corp. lowest stock price was $10.25 and its highest was $10.80 in the past 12 months.
What is Translational Development Acquisition Corp.’s market cap?
Translational Development Acquisition Corp.’s market cap is $234.63M.
When is Translational Development Acquisition Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Translational Development Acquisition Corp.’s earnings last quarter?
Currently, no data Available
Is Translational Development Acquisition Corp. overvalued?
According to Wall Street analysts Translational Development Acquisition Corp.’s price is currently Overvalued.
Does Translational Development Acquisition Corp. pay dividends?
Translational Development Acquisition Corp. does not currently pay dividends.
What is Translational Development Acquisition Corp.’s EPS estimate?
Translational Development Acquisition Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Translational Development Acquisition Corp. have?
Translational Development Acquisition Corp. has 21,907,500 shares outstanding.
What happened to Translational Development Acquisition Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Translational Development Acquisition Corp.?
Currently, no hedge funds are holding shares in TDAC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Translational Development Acquisition Corp. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
3.57%
Trailing 12-Months
Asset Growth
3.82%
Trailing 12-Months
Company Description
Translational Development Acquisition Corp.
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.
Technical Analysis
Ownership Overview
―
Insiders
3.65% Mutual Funds
47.16% Other Institutional Investors
49.15% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---